(Q39812687)

14 September 2017

RAS signaling dysregulation in human embryonal Rhabdomyosarcoma (English)

1 reference

14 September 2017

1 reference

6

1 reference

14 September 2017

Silvia Delle Vigne

3

0 references

author name string

Simone Martinelli

1

1 reference

14 September 2017

Heather P McDowell

2

1 reference

14 September 2017

George Kokai

4

1 reference

14 September 2017

Stefania Uccini

5

1 reference

14 September 2017

Carlo Dominici

7

1 reference

14 September 2017

1 November 2009

1 reference

Genes, Chromosomes and Cancer

14 September 2017

1 reference

14 September 2017

48

1 reference

14 September 2017

975-982

1 reference

14 September 2017

11

1 reference

Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma

14 September 2017

1 reference

Molecular pathogenesis of rhabdomyosarcoma

21 January 2018

1 reference

Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas

21 January 2018

1 reference

7 January 2021

European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors

1 reference

7 January 2021

The type of K-ras mutation determines prognosis in colorectal cancer

1 reference

7 January 2021

N-ras gene activation in the RD human rhabdomyosarcoma cell line.

1 reference

7 January 2021

Mutations of the PTPN11 and RAS genes in rhabdomyosarcoma and pediatric hematological malignancies

1 reference

7 January 2021

Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations

1 reference

7 January 2021

Biological and biochemical properties of human rasH genes mutated at codon 61.

1 reference

7 January 2021

Paratesticular rhabdomyosarcoma: report from the Italian and German Cooperative Group

1 reference

7 January 2021

ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer.

1 reference

7 January 2021

Ras-effector interactions: after one decade

1 reference

7 January 2021

Crystal structure of the tyrosine phosphatase SHP-2

1 reference

7 January 2021

Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation

1 reference

7 January 2021

Uniparental disomy at chromosome 11p15.5 followed by HRAS mutations in embryonal rhabdomyosarcoma: lessons from Costello syndrome.

1 reference

7 January 2021

Effects of RAS on the genesis of embryonal rhabdomyosarcoma.

1 reference

7 January 2021

Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.

1 reference

7 January 2021

Activating PTPN11 mutations play a minor role in pediatric and adult solid tumors

1 reference

7 January 2021

The Intergroup Rhabdomyosarcoma Study-I. A final report

1 reference

7 January 2021

Update on childhood rhabdomyosarcoma

1 reference

7 January 2021

Imatinib mesylate potentiates topotecan antitumor activity in rhabdomyosarcoma preclinical models

1 reference

7 January 2021

Signaling interplay in Ras superfamily function

1 reference

7 January 2021

Implications and prognostic value of K-ras mutation for early-stage lung cancer in women

1 reference

7 January 2021

Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma

1 reference

7 January 2021

Tumorigenesis in neurofibromatosis: new insights and potential therapies

1 reference

7 January 2021

Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum

1 reference

7 January 2021

Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.

1 reference

7 January 2021

MicroRNA expression signature of human sarcomas.

1 reference

7 January 2021

Germ-line and somatic PTPN11 mutations in human disease

1 reference

7 January 2021

Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome

1 reference

7 January 2021

PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity

1 reference

7 January 2021

Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia

1 reference

7 January 2021

Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia

1 reference

7 January 2021

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease

1 reference

7 January 2021

A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants

1 reference

7 January 2021

Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice

1 reference

7 January 2021

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

1 reference

7 January 2021

BRAF mutation in thyroid cancer

1 reference

7 January 2021

Identifiers

DOI

10.1002/GCC.20702

1 reference

14 September 2017

1 reference